Abramson Cancer Center and Perelman Center for Advanced Medicine ( Site 0131), Philadelphia
Temple University Hospital ( Site 0133), Philadelphia
Alliance Cancer Specialists (ACS) ( Site 8010), Sellersville
og 1 flere

RekruttererFase 2

Alder 18 og opefter · Alle køn · Opdateret 25. sep. 2026 · NCT06890884

A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )

University of Pennsylvania Abramson Cancer Center, Philadelphia

RekruttererFase 1

Alder 18 og opefter · Alle køn · Opdateret 22. sep. 2026 · NCT07101328

Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)

Children's Hospital of Philadelphia (CHOP) ( Site 1021), Philadelphia

RekruttererFase 1/2

6 Months – 25 Years · Alle køn · Opdateret 17. sep. 2026 · NCT06395103

Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma

Lehigh Valley Topper Cancer Center Institute, Allentown
Thomas Jefferson University, Philadelphia
West Penn Hospital, Pittsburgh

RekruttererFase 1/2

Alder 18 og opefter · Alle køn · Opdateret 25. aug. 2026 · NCT05826535

A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas

Abramson Cancer Center of the University of Pennsylvania, Philadelphia

RekruttererFase 1/2

Alder 18 og opefter · Alle køn · Opdateret 19. aug. 2026 · NCT04104776

A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy

Allegheny Health Network, Pittsburgh

RekruttererFase 3

Alder 18 og opefter · Alle køn · Opdateret 4. aug. 2026 · NCT07188558

DALY II USA/ MB-CART2019.1 for DLBCL

Allegheny Health Network Cancer Institute, Pittsburgh

RekruttererFase 2

Alder 18 og opefter · Alle køn · Opdateret 13. jul. 2026 · NCT04792489

Immune Cell Therapy (CAR-T) for the Treatment of Patients With HIV and B-Cell Non-Hodgkin Lymphoma

University of Pennsylvania / Abramson Cancer Center, Philadelphia

RekruttererFase 1

Alder 18 og opefter · Alle køn · Opdateret 10. jul. 2026 · NCT05077527

A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies

University of Pennsylvania, Abramson Cancer Center, Philadelphia

RekruttererFase 1

Alder 18 og opefter · Alle køn · Opdateret 2. jul. 2026 · NCT05131022

Radiation, Oral Vancomycin, and CAR-T for B-Cell Lymphomas

Abramson Cancer Center, University of Pennsylvania, Philadelphia

RekruttererFase 1

Alder 18 og opefter · Alle køn · Opdateret 1. jul. 2026 · NCT07478848

Epcoritamab-CAR T Cells for Large B-cell Lymphomas

Abramson Cancer Center at the University of Pennsylvania, Philadelphia

RekruttererFase 2

Alder 18 og opefter · Alle køn · Opdateret 27. maj 2026 · NCT06458439

SynKIR-310 for Relapsed/Refractory B-NHL

Abramson Cancer Center of the University of Pennsylvania, Philadelphia

RekruttererFase 1

Alder 18 og opefter · Alle køn · Opdateret 14. apr. 2026 · NCT06544265

Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma

Geisinger Medical Center, Danville
University of Pennsylvania/Abramson Cancer Center, Philadelphia
Geisinger Wyoming Valley/Henry Cancer Center, Wilkes-Barre

RekruttererFase 2

Alder 18 og opefter · Alle køn · Opdateret 2. feb. 2026 · NCT05633615

Local Manufacture of CAR T-Cell Products for the Treatment of B-Cell Lymphoma and B-Acute Lymphoblastic Leukemia

AHN Cancer Institute - West Penn Hospital, Pittsburgh

RekruttererFase 2

Alder 18 til 79 · Alle køn · Opdateret 13. jan. 2025 · NCT05281809

DPX-Survivac and Pembrolizumab With and Without Intermittent Low-Dose Cyclophosphamide, in Subjects With Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Allegheny Health Network (AHN) West Penn Hospital, Pittsburgh
Reading Hospital - McGlinn Cancer Institute, West Reading

RekruttererFase 2

Alder 18 og opefter · Alle køn · Opdateret 7. apr. 2023 · NCT04920617

Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.